SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-001671
Filing Date
2019-01-03
Accepted
2019-01-03 17:20:38
Documents
1
Group Members
ADAM GRAYCHRISTOPHER SHACKELTONCOLISEUM CAPITAL PARTNERS II, L.P.COLISEUM CAPITAL PARTNERS, L.P.COLISEUM CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d684145dsc13da.htm SC 13D/A 107267
  Complete submission text file 0001193125-19-001671.txt   108991
Mailing Address 1600 BROADWAY SUITE 950 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 950 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Subject) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49459 | Film No.: 19507004
SIC: 8082 Services-Home Health Care Services

Mailing Address 105 ROWAYTON AVENUE ROWAYTON CT 06853
Business Address 105 ROWAYTON AVENUE ROWAYTON CT 06853 203-883-0100
Coliseum Capital Management, LLC (Filed by) CIK: 0001409751 (see all company filings)

IRS No.: 223918079 | State of Incorp.: DE
Type: SC 13D/A